What we do
GenomOncology has developed a proprietary technology platform to streamline the use of next generation sequencing data (NGS) in medicine and research.
Everything necessary for a molecular pathology lab to efficiently design, validate and operate an NGS-based Laboratory Developed Test (LDT),
including software, expertise, integration technology and on-site training, is provided by GenomOncology.
Who we are
GenomOncology is focused on enabling precision medicine by translating next generation sequencing data into actionable information for clinicians and researchers.